Loading…
Immunogenicity and immunoprotection of the functional TL-HN fragment derived from tetanus toxin
•TL-HN afforded the best immunoprotection among all the TeNT functional domains.•TL + THN combination showed no synergistic effect on protective potency against TeNT.•There are important neutralizing antibody epitopes at L and HN domains of TeNT.•TL-HN lacking the Hc domain is a good candidate subun...
Saved in:
Published in: | Vaccine 2023-11, Vol.41 (46), p.6834-6841 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c374t-612231bbff8da9fc3ea1647dc7ba9d3c8919a9c2432bdb46dbccbb6a9a92f6863 |
container_end_page | 6841 |
container_issue | 46 |
container_start_page | 6834 |
container_title | Vaccine |
container_volume | 41 |
creator | Liu, Xu-Yang Wei, Dong-Kui Li, Zhi-Ying Lu, Jian-Sheng Xie, Xin-Mei Yu, Yun-Zhou Pang, Xiao-Bin |
description | •TL-HN afforded the best immunoprotection among all the TeNT functional domains.•TL + THN combination showed no synergistic effect on protective potency against TeNT.•There are important neutralizing antibody epitopes at L and HN domains of TeNT.•TL-HN lacking the Hc domain is a good candidate subunit vaccine against TeNT.
Tetanus toxin (TeNT) is a protein toxin produced by Clostridium tetani bacteria, which causes hyperreflexia and rhabdomyolysis by spastic paralysis. Like botulinum neurotoxin, TeNT comprises a heavy chain (HC) and a light chain (LC) linked via an interchain disulfide bond, which include the following three functional domains: a receptor-binding domain (Hc), a translocation domain (HN), and a catalytic domain (LC). Herein, we produced and characterized three functional domains of TeNT and three types of TeNT-derived L-HN fragments (TL-HN, TL-GS-HN and TL-2A-HN), which contained L and HN domains but lacked the Hc domain. The immunological effects of these different functional domains or fragments of TeNT were explored in an animal model. Our investigations showed the TL-HN functional fragment provided the best immunoprotection among all the TeNT functional domains. The TL–HN fragment, as a protective antigen, induced the highest levels of neutralizing antibodies, indicating that it might contain some crucial epitopes. Further experiments revealed that the protective effect of TL-HN was superior to that of the THc, TL, or THN fragments, either individually or in combination. Therefore, the TL-HN fragment exerts an important function in immune protection against tetanus toxin, providing a good basis for the development of TeNT vaccines or antibodies, and could serve as a promising subunit vaccine to replace THc or tetanus toxoid (TT). |
doi_str_mv | 10.1016/j.vaccine.2023.09.032 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3153674919</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0264410X23011027</els_id><sourcerecordid>2883296783</sourcerecordid><originalsourceid>FETCH-LOGICAL-c374t-612231bbff8da9fc3ea1647dc7ba9d3c8919a9c2432bdb46dbccbb6a9a92f6863</originalsourceid><addsrcrecordid>eNqFkU9vFCEYh4nR2G31I2hIvHiZKX9mGDgZ02jbZFMvbdIbYeCdymYHKjAb--1lu6sHLz0RfnneH-R9EPpASUsJFeebdmes9QFaRhhviWoJZ6_QisqBN6yn8jVaESa6pqPk_gSd5rwhhPScqrfohA-SCtF3K6Sv53kJ8QGCt748YRMc9s_RY4oFbPEx4Djh8hPwtITnu9ni23VzdYOnZB5mCAU7SH4HrgZxxgWKCUvGJf724R16M5lthvfH8wzdff92e3HVrH9cXl98XTeWD11pBGWM03GcJumMmiwHQ0U3ODuMRjlupaLKKMs6zkY3dsKN1o6jMDVkk5CCn6HPh9767V8L5KJnny1styZAXLLmtOdi6GrNiyiTQy97pkhX0U__oZu4pLqAPSU5U2KQvFL9gbIp5pxg0o_JzyY9aUr0Xpbe6KMsvZelidJVVp37eGxfxhncv6m_dirw5QBA3dzOQ9LZeggWnE9VjXbRv_DEHxB2qUA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2883296783</pqid></control><display><type>article</type><title>Immunogenicity and immunoprotection of the functional TL-HN fragment derived from tetanus toxin</title><source>ScienceDirect Journals</source><creator>Liu, Xu-Yang ; Wei, Dong-Kui ; Li, Zhi-Ying ; Lu, Jian-Sheng ; Xie, Xin-Mei ; Yu, Yun-Zhou ; Pang, Xiao-Bin</creator><creatorcontrib>Liu, Xu-Yang ; Wei, Dong-Kui ; Li, Zhi-Ying ; Lu, Jian-Sheng ; Xie, Xin-Mei ; Yu, Yun-Zhou ; Pang, Xiao-Bin</creatorcontrib><description>•TL-HN afforded the best immunoprotection among all the TeNT functional domains.•TL + THN combination showed no synergistic effect on protective potency against TeNT.•There are important neutralizing antibody epitopes at L and HN domains of TeNT.•TL-HN lacking the Hc domain is a good candidate subunit vaccine against TeNT.
Tetanus toxin (TeNT) is a protein toxin produced by Clostridium tetani bacteria, which causes hyperreflexia and rhabdomyolysis by spastic paralysis. Like botulinum neurotoxin, TeNT comprises a heavy chain (HC) and a light chain (LC) linked via an interchain disulfide bond, which include the following three functional domains: a receptor-binding domain (Hc), a translocation domain (HN), and a catalytic domain (LC). Herein, we produced and characterized three functional domains of TeNT and three types of TeNT-derived L-HN fragments (TL-HN, TL-GS-HN and TL-2A-HN), which contained L and HN domains but lacked the Hc domain. The immunological effects of these different functional domains or fragments of TeNT were explored in an animal model. Our investigations showed the TL-HN functional fragment provided the best immunoprotection among all the TeNT functional domains. The TL–HN fragment, as a protective antigen, induced the highest levels of neutralizing antibodies, indicating that it might contain some crucial epitopes. Further experiments revealed that the protective effect of TL-HN was superior to that of the THc, TL, or THN fragments, either individually or in combination. Therefore, the TL-HN fragment exerts an important function in immune protection against tetanus toxin, providing a good basis for the development of TeNT vaccines or antibodies, and could serve as a promising subunit vaccine to replace THc or tetanus toxoid (TT).</description><identifier>ISSN: 0264-410X</identifier><identifier>ISSN: 1873-2518</identifier><identifier>EISSN: 1873-2518</identifier><identifier>DOI: 10.1016/j.vaccine.2023.09.032</identifier><identifier>PMID: 37816654</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>active sites ; Animal models ; Animals ; Antibodies ; Antibodies, Bacterial - blood ; Antibodies, Bacterial - immunology ; Antibodies, Neutralizing - immunology ; Antigens ; Botulinum toxin ; Chemical bonds ; Clostridium tetani ; Cytoplasm ; disulfide bonds ; domain ; E coli ; Epitopes ; Female ; Fragments ; Functional domain ; Immune protection ; Immunization ; Immunogenicity ; Immunology ; Laboratory animals ; Mice ; Mice, Inbred BALB C ; Neurotoxicity ; Neurotoxins ; Paralysis ; Peptide Fragments - immunology ; Plasmids ; Poisoning ; Protective antigen ; protective effect ; Proteins ; Rhabdomyolysis ; Subunit vaccine ; subunit vaccines ; Tetanus ; Tetanus - immunology ; Tetanus - prevention & control ; Tetanus toxin ; Tetanus Toxin - immunology ; TL-HN fragment ; Toxins ; Translocation ; Vaccines</subject><ispartof>Vaccine, 2023-11, Vol.41 (46), p.6834-6841</ispartof><rights>2023 Elsevier Ltd</rights><rights>Copyright © 2023 Elsevier Ltd. All rights reserved.</rights><rights>2023. Elsevier Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c374t-612231bbff8da9fc3ea1647dc7ba9d3c8919a9c2432bdb46dbccbb6a9a92f6863</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37816654$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Liu, Xu-Yang</creatorcontrib><creatorcontrib>Wei, Dong-Kui</creatorcontrib><creatorcontrib>Li, Zhi-Ying</creatorcontrib><creatorcontrib>Lu, Jian-Sheng</creatorcontrib><creatorcontrib>Xie, Xin-Mei</creatorcontrib><creatorcontrib>Yu, Yun-Zhou</creatorcontrib><creatorcontrib>Pang, Xiao-Bin</creatorcontrib><title>Immunogenicity and immunoprotection of the functional TL-HN fragment derived from tetanus toxin</title><title>Vaccine</title><addtitle>Vaccine</addtitle><description>•TL-HN afforded the best immunoprotection among all the TeNT functional domains.•TL + THN combination showed no synergistic effect on protective potency against TeNT.•There are important neutralizing antibody epitopes at L and HN domains of TeNT.•TL-HN lacking the Hc domain is a good candidate subunit vaccine against TeNT.
Tetanus toxin (TeNT) is a protein toxin produced by Clostridium tetani bacteria, which causes hyperreflexia and rhabdomyolysis by spastic paralysis. Like botulinum neurotoxin, TeNT comprises a heavy chain (HC) and a light chain (LC) linked via an interchain disulfide bond, which include the following three functional domains: a receptor-binding domain (Hc), a translocation domain (HN), and a catalytic domain (LC). Herein, we produced and characterized three functional domains of TeNT and three types of TeNT-derived L-HN fragments (TL-HN, TL-GS-HN and TL-2A-HN), which contained L and HN domains but lacked the Hc domain. The immunological effects of these different functional domains or fragments of TeNT were explored in an animal model. Our investigations showed the TL-HN functional fragment provided the best immunoprotection among all the TeNT functional domains. The TL–HN fragment, as a protective antigen, induced the highest levels of neutralizing antibodies, indicating that it might contain some crucial epitopes. Further experiments revealed that the protective effect of TL-HN was superior to that of the THc, TL, or THN fragments, either individually or in combination. Therefore, the TL-HN fragment exerts an important function in immune protection against tetanus toxin, providing a good basis for the development of TeNT vaccines or antibodies, and could serve as a promising subunit vaccine to replace THc or tetanus toxoid (TT).</description><subject>active sites</subject><subject>Animal models</subject><subject>Animals</subject><subject>Antibodies</subject><subject>Antibodies, Bacterial - blood</subject><subject>Antibodies, Bacterial - immunology</subject><subject>Antibodies, Neutralizing - immunology</subject><subject>Antigens</subject><subject>Botulinum toxin</subject><subject>Chemical bonds</subject><subject>Clostridium tetani</subject><subject>Cytoplasm</subject><subject>disulfide bonds</subject><subject>domain</subject><subject>E coli</subject><subject>Epitopes</subject><subject>Female</subject><subject>Fragments</subject><subject>Functional domain</subject><subject>Immune protection</subject><subject>Immunization</subject><subject>Immunogenicity</subject><subject>Immunology</subject><subject>Laboratory animals</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Neurotoxicity</subject><subject>Neurotoxins</subject><subject>Paralysis</subject><subject>Peptide Fragments - immunology</subject><subject>Plasmids</subject><subject>Poisoning</subject><subject>Protective antigen</subject><subject>protective effect</subject><subject>Proteins</subject><subject>Rhabdomyolysis</subject><subject>Subunit vaccine</subject><subject>subunit vaccines</subject><subject>Tetanus</subject><subject>Tetanus - immunology</subject><subject>Tetanus - prevention & control</subject><subject>Tetanus toxin</subject><subject>Tetanus Toxin - immunology</subject><subject>TL-HN fragment</subject><subject>Toxins</subject><subject>Translocation</subject><subject>Vaccines</subject><issn>0264-410X</issn><issn>1873-2518</issn><issn>1873-2518</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNqFkU9vFCEYh4nR2G31I2hIvHiZKX9mGDgZ02jbZFMvbdIbYeCdymYHKjAb--1lu6sHLz0RfnneH-R9EPpASUsJFeebdmes9QFaRhhviWoJZ6_QisqBN6yn8jVaESa6pqPk_gSd5rwhhPScqrfohA-SCtF3K6Sv53kJ8QGCt748YRMc9s_RY4oFbPEx4Djh8hPwtITnu9ni23VzdYOnZB5mCAU7SH4HrgZxxgWKCUvGJf724R16M5lthvfH8wzdff92e3HVrH9cXl98XTeWD11pBGWM03GcJumMmiwHQ0U3ODuMRjlupaLKKMs6zkY3dsKN1o6jMDVkk5CCn6HPh9767V8L5KJnny1styZAXLLmtOdi6GrNiyiTQy97pkhX0U__oZu4pLqAPSU5U2KQvFL9gbIp5pxg0o_JzyY9aUr0Xpbe6KMsvZelidJVVp37eGxfxhncv6m_dirw5QBA3dzOQ9LZeggWnE9VjXbRv_DEHxB2qUA</recordid><startdate>20231102</startdate><enddate>20231102</enddate><creator>Liu, Xu-Yang</creator><creator>Wei, Dong-Kui</creator><creator>Li, Zhi-Ying</creator><creator>Lu, Jian-Sheng</creator><creator>Xie, Xin-Mei</creator><creator>Yu, Yun-Zhou</creator><creator>Pang, Xiao-Bin</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7T2</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><scope>7S9</scope><scope>L.6</scope></search><sort><creationdate>20231102</creationdate><title>Immunogenicity and immunoprotection of the functional TL-HN fragment derived from tetanus toxin</title><author>Liu, Xu-Yang ; Wei, Dong-Kui ; Li, Zhi-Ying ; Lu, Jian-Sheng ; Xie, Xin-Mei ; Yu, Yun-Zhou ; Pang, Xiao-Bin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c374t-612231bbff8da9fc3ea1647dc7ba9d3c8919a9c2432bdb46dbccbb6a9a92f6863</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>active sites</topic><topic>Animal models</topic><topic>Animals</topic><topic>Antibodies</topic><topic>Antibodies, Bacterial - blood</topic><topic>Antibodies, Bacterial - immunology</topic><topic>Antibodies, Neutralizing - immunology</topic><topic>Antigens</topic><topic>Botulinum toxin</topic><topic>Chemical bonds</topic><topic>Clostridium tetani</topic><topic>Cytoplasm</topic><topic>disulfide bonds</topic><topic>domain</topic><topic>E coli</topic><topic>Epitopes</topic><topic>Female</topic><topic>Fragments</topic><topic>Functional domain</topic><topic>Immune protection</topic><topic>Immunization</topic><topic>Immunogenicity</topic><topic>Immunology</topic><topic>Laboratory animals</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Neurotoxicity</topic><topic>Neurotoxins</topic><topic>Paralysis</topic><topic>Peptide Fragments - immunology</topic><topic>Plasmids</topic><topic>Poisoning</topic><topic>Protective antigen</topic><topic>protective effect</topic><topic>Proteins</topic><topic>Rhabdomyolysis</topic><topic>Subunit vaccine</topic><topic>subunit vaccines</topic><topic>Tetanus</topic><topic>Tetanus - immunology</topic><topic>Tetanus - prevention & control</topic><topic>Tetanus toxin</topic><topic>Tetanus Toxin - immunology</topic><topic>TL-HN fragment</topic><topic>Toxins</topic><topic>Translocation</topic><topic>Vaccines</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Liu, Xu-Yang</creatorcontrib><creatorcontrib>Wei, Dong-Kui</creatorcontrib><creatorcontrib>Li, Zhi-Ying</creatorcontrib><creatorcontrib>Lu, Jian-Sheng</creatorcontrib><creatorcontrib>Xie, Xin-Mei</creatorcontrib><creatorcontrib>Yu, Yun-Zhou</creatorcontrib><creatorcontrib>Pang, Xiao-Bin</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing & Allied Health Database</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>AGRICOLA</collection><collection>AGRICOLA - Academic</collection><jtitle>Vaccine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Liu, Xu-Yang</au><au>Wei, Dong-Kui</au><au>Li, Zhi-Ying</au><au>Lu, Jian-Sheng</au><au>Xie, Xin-Mei</au><au>Yu, Yun-Zhou</au><au>Pang, Xiao-Bin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Immunogenicity and immunoprotection of the functional TL-HN fragment derived from tetanus toxin</atitle><jtitle>Vaccine</jtitle><addtitle>Vaccine</addtitle><date>2023-11-02</date><risdate>2023</risdate><volume>41</volume><issue>46</issue><spage>6834</spage><epage>6841</epage><pages>6834-6841</pages><issn>0264-410X</issn><issn>1873-2518</issn><eissn>1873-2518</eissn><abstract>•TL-HN afforded the best immunoprotection among all the TeNT functional domains.•TL + THN combination showed no synergistic effect on protective potency against TeNT.•There are important neutralizing antibody epitopes at L and HN domains of TeNT.•TL-HN lacking the Hc domain is a good candidate subunit vaccine against TeNT.
Tetanus toxin (TeNT) is a protein toxin produced by Clostridium tetani bacteria, which causes hyperreflexia and rhabdomyolysis by spastic paralysis. Like botulinum neurotoxin, TeNT comprises a heavy chain (HC) and a light chain (LC) linked via an interchain disulfide bond, which include the following three functional domains: a receptor-binding domain (Hc), a translocation domain (HN), and a catalytic domain (LC). Herein, we produced and characterized three functional domains of TeNT and three types of TeNT-derived L-HN fragments (TL-HN, TL-GS-HN and TL-2A-HN), which contained L and HN domains but lacked the Hc domain. The immunological effects of these different functional domains or fragments of TeNT were explored in an animal model. Our investigations showed the TL-HN functional fragment provided the best immunoprotection among all the TeNT functional domains. The TL–HN fragment, as a protective antigen, induced the highest levels of neutralizing antibodies, indicating that it might contain some crucial epitopes. Further experiments revealed that the protective effect of TL-HN was superior to that of the THc, TL, or THN fragments, either individually or in combination. Therefore, the TL-HN fragment exerts an important function in immune protection against tetanus toxin, providing a good basis for the development of TeNT vaccines or antibodies, and could serve as a promising subunit vaccine to replace THc or tetanus toxoid (TT).</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>37816654</pmid><doi>10.1016/j.vaccine.2023.09.032</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0264-410X |
ispartof | Vaccine, 2023-11, Vol.41 (46), p.6834-6841 |
issn | 0264-410X 1873-2518 1873-2518 |
language | eng |
recordid | cdi_proquest_miscellaneous_3153674919 |
source | ScienceDirect Journals |
subjects | active sites Animal models Animals Antibodies Antibodies, Bacterial - blood Antibodies, Bacterial - immunology Antibodies, Neutralizing - immunology Antigens Botulinum toxin Chemical bonds Clostridium tetani Cytoplasm disulfide bonds domain E coli Epitopes Female Fragments Functional domain Immune protection Immunization Immunogenicity Immunology Laboratory animals Mice Mice, Inbred BALB C Neurotoxicity Neurotoxins Paralysis Peptide Fragments - immunology Plasmids Poisoning Protective antigen protective effect Proteins Rhabdomyolysis Subunit vaccine subunit vaccines Tetanus Tetanus - immunology Tetanus - prevention & control Tetanus toxin Tetanus Toxin - immunology TL-HN fragment Toxins Translocation Vaccines |
title | Immunogenicity and immunoprotection of the functional TL-HN fragment derived from tetanus toxin |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T14%3A16%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Immunogenicity%20and%20immunoprotection%20of%20the%20functional%20TL-HN%20fragment%20derived%20from%20tetanus%20toxin&rft.jtitle=Vaccine&rft.au=Liu,%20Xu-Yang&rft.date=2023-11-02&rft.volume=41&rft.issue=46&rft.spage=6834&rft.epage=6841&rft.pages=6834-6841&rft.issn=0264-410X&rft.eissn=1873-2518&rft_id=info:doi/10.1016/j.vaccine.2023.09.032&rft_dat=%3Cproquest_cross%3E2883296783%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c374t-612231bbff8da9fc3ea1647dc7ba9d3c8919a9c2432bdb46dbccbb6a9a92f6863%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2883296783&rft_id=info:pmid/37816654&rfr_iscdi=true |